Search

Your search keyword '"Michael Z David"' showing total 66 results

Search Constraints

Start Over You searched for: Author "Michael Z David" Remove constraint Author: "Michael Z David" Topic medicine.disease_cause Remove constraint Topic: medicine.disease_cause
66 results on '"Michael Z David"'

Search Results

1. Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center

2. Staphylococcus aureus Skin and Soft Tissue Infection Recurrence Rates in Outpatients: A Retrospective Database Study at 3 US Medical Centers

3. Healthcare Micro-Environments Define Multidrug-Resistant Organism Persistence

4. Genomic Epidemiology and Global Population Structure of Exfoliative Toxin A-Producing Staphylococcus aureus Strains Associated With Staphylococcal Scalded Skin Syndrome

5. Complete Genome Sequence of Exfoliative Toxin-Producing Staphylococcus aureus Strain MSSA_SSSS_01, Obtained from a Case of Staphylococcal Scalded-Skin Syndrome

6. Evolution and Population Dynamics of Clonal Complex 152 Community-Associated Methicillin-Resistant Staphylococcus aureus

7. Decreasing Incidence of Skin and Soft-tissue Infections in 86 US Emergency Departments, 2009–2014

9. Future trends in the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infection: An in-depth review of newer antibiotics active against an enduring pathogen

10. 852. Genomic Clusters of Methicillin-Resistant Staphylococcus aureus (MRSA) Causing Bloodstream Infections (BSIs) in Hospitalized Adults, 2018-19

11. 157. patient to Environment Transmission of Multidrug-resistant Bacteria Within Intensive Care Units

12. Antimicrobial Resistance in Methicillin-Resistant Staphylococcus aureus to Newer Antimicrobial Agents

13. Long-Term Intrahost Evolution of Methicillin Resistant Staphylococcus aureus Among Cystic Fibrosis Patients With Respiratory Carriage

14. USA300 Staphylococcus aureus persists on multiple body sites following an infection

15. An update on Staphylococcus aureus infective endocarditis from the International Society of Antimicrobial Chemotherapy (ISAC)

16. In Vitro Susceptibility of Ciprofloxacin-Resistant Methicillin-Resistant Staphylococcus aureus to Ototopical Therapy

17. USA300 Methicillin-ResistantStaphylococcus aureus, United States, 2000–2013

18. Pediatric Staphylococcus aureus Isolate Genotypes and Infections from the Dawn of the Community-Associated Methicillin-Resistant S. aureus Epidemic Era in Chicago, 1994 to 1997

19. Corrigendum to 'Panton-Valentine Leucocidin (PVL) Staphylococcus aureus a position statement from the International Society of Chemotherapy' [International Journal of Antimicrobial Agents 51/1 (2018) 16-25]

20. USA300 MRSA lineages persist on multiple body sites following infection

21. Diffusion of clindamycin-resistant and erythromycin-resistant methicillin-susceptible Staphylococcus aureus (MSSA), potential ST398, in United States Veterans Health Administration Hospitals, 2003-2014

22. Hand and Nasal Carriage of Discordant Staphylococcus aureus Isolates among Urban Jail Detainees

23. The economic burden of community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)

24. Comparing Pulsed-Field Gel Electrophoresis with Multilocus Sequence Typing, spa Typing, Staphylococcal Cassette Chromosome mec (SCC mec ) Typing, and PCR for Panton-Valentine Leukocidin, arcA , and opp3 in Methicillin-Resistant Staphylococcus aureus Isolates at a U.S. Medical Center

25. Treatment of Staphylococcus aureus Infections

26. Recently approved antibacterials for methicillin-resistant Staphylococcus aureus (MRSA) and other Gram-positive pathogens: the shock of the new

27. Decreasing Incidence of Skin and Soft Tissue Infections With a Seasonal Pattern at an Academic Medical Center, 2006–2014

28. Bacterial and viral co-infections complicating severe influenza: Incidence and impact among 507 U.S. patients, 2013-14

29. Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans

30. Intrahost Evolution of Methicillin-Resistant Staphylococcus aureus USA300 Among Individuals With Reoccurring Skin and Soft-Tissue Infections

31. Increasing Burden of Methicillin-Resistant Staphylococcus aureus Hospitalizations at US Academic Medical Centers, 2003–2008

32. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance

33. MRSA USA300 at Alaska Native Medical Center, Anchorage, Alaska, USA, 2000–2006

34. Molecular Epidemiology of Methicillin-ResistantStaphylococcus aureus, Rural Southwestern Alaska1

35. Complex Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus Isolates From Children With Cystic Fibrosis in the Era of Epidemic Community-Associated Methicillin-Resistant S aureus

36. What Is Community‐Associated Methicillin‐ResistantStaphylococcus aureus?

38. Severe Influenza in 33 US Hospitals, 2013-2014: Complications and Risk Factors for Death in 507 Patients

39. USA300 and USA500 Clonal Lineages of Staphylococcus aureus Do Not Produce a Capsular Polysaccharide Due to Conserved Mutations in the cap5 Locus

40. Transmission and microevolution of USA300 MRSA in U.S. households: evidence from whole-genome sequencing

41. Contrasting Pediatric and Adult Methicillin-resistant Staphylococcus aureus Isolates

42. High Staphylococcus aureus Colonization Prevalence among Patients with Skin and Soft Tissue Infections and Controls in an Urban Emergency Department

43. Whole-Genome Sequencing (WGS) of 19 Methicillin-Resistant Staphylococcus aureus (MRSA) Isolates From Recurrent Infections in 4 Patients: USA300 Strain Replacement

44. Staphylococcus aureus skin infection recurrences among household members: an examination of host, behavioral, and pathogen-level predictors

45. A randomized, controlled trial of chlorhexidine-soaked cloths to reduce methicillin-resistant and methicillin-susceptible Staphylococcus aureus carriage prevalence in an urban jail

46. Persistent environmental contamination with USA300 methicillin-resistant Staphylococcus aureus and other pathogenic strain types in households with S. aureus skin infections

47. Staphylococcus aureus bacteremia at 5 US academic medical centers, 2008-2011: significant geographic variation in community-onset infections

48. Predictors of skin and soft tissue infections in HIV-infected outpatients in the community-associated methicillin-resistant Staphylococcus aureus era

49. A national survey of skin infections, care behaviors and MRSA knowledge in the United States

50. Preventing introduction of methicillin-resistant Staphylococcus aureus into hospitals

Catalog

Books, media, physical & digital resources